These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
557 related items for PubMed ID: 15001694
1. Kinetics of perrhenate uptake and comparative biodistribution of perrhenate, pertechnetate, and iodide by NaI symporter-expressing tissues in vivo. Zuckier LS, Dohan O, Li Y, Chang CJ, Carrasco N, Dadachova E. J Nucl Med; 2004 Mar; 45(3):500-7. PubMed ID: 15001694 [Abstract] [Full Text] [Related]
2. Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy. Kang JH, Chung JK, Lee YJ, Shin JH, Jeong JM, Lee DS, Lee MC. J Nucl Med; 2004 Sep; 45(9):1571-6. PubMed ID: 15347726 [Abstract] [Full Text] [Related]
3. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter. Petrich T, Helmeke HJ, Meyer GJ, Knapp WH, Pötter E. Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):842-54. PubMed ID: 12111124 [Abstract] [Full Text] [Related]
4. Anion selectivity by the sodium iodide symporter. Van Sande J, Massart C, Beauwens R, Schoutens A, Costagliola S, Dumont JE, Wolff J. Endocrinology; 2003 Jan; 144(1):247-52. PubMed ID: 12488351 [Abstract] [Full Text] [Related]
6. Development of a sodium/iodide symporter (NIS)-transgenic mouse for imaging of cardiomyocyte-specific reporter gene expression. Kang JH, Lee DS, Paeng JC, Lee JS, Kim YH, Lee YJ, Hwang DW, Jeong JM, Lim SM, Chung JK, Lee MC. J Nucl Med; 2005 Mar; 46(3):479-83. PubMed ID: 15750162 [Abstract] [Full Text] [Related]
7. 99mTc-pertechnetate uptake in hepatoma cells due to tissue-specific human sodium iodide symporter gene expression. Chen L, Altman A, Mier W, Lu H, Zhu R, Haberkorn U. Nucl Med Biol; 2006 May; 33(4):575-80. PubMed ID: 16720251 [Abstract] [Full Text] [Related]
8. Distribution and dynamics of (99m)Tc-pertechnetate uptake in the thyroid and other organs assessed by single-photon emission computed tomography in living mice. Franken PR, Guglielmi J, Vanhove C, Koulibaly M, Defrise M, Darcourt J, Pourcher T. Thyroid; 2010 May; 20(5):519-26. PubMed ID: 20384490 [Abstract] [Full Text] [Related]
9. Treatment with rhenium-188-perrhenate and iodine-131 of NIS-expressing mammary cancer in a mouse model remarkably inhibited tumor growth. Dadachova E, Nguyen A, Lin EY, Gnatovskiy L, Lu P, Pollard JW. Nucl Med Biol; 2005 Oct; 32(7):695-700. PubMed ID: 16243644 [Abstract] [Full Text] [Related]
10. In vitro and in vivo properties of a human anaplastic thyroid carcinoma cell line transfected with the sodium iodide symporter gene. Lee YJ, Chung JK, Shin JH, Kang JH, Jeong JM, Lee DS, Lee MC. Thyroid; 2004 Nov; 14(11):889-95. PubMed ID: 15671766 [Abstract] [Full Text] [Related]
11. Pharmacokinetics of 99Tcm-pertechnetate and 188Re-perrhenate after oral administration of perchlorate: option for subsequent care after the use of liquid 188Re in a balloon catheter. Kotzerke J, Fenchel S, Guhlmann A, Stabin M, Rentschler M, Knapp FF, Reske SN. Nucl Med Commun; 1998 Aug; 19(8):795-801. PubMed ID: 9751935 [Abstract] [Full Text] [Related]
12. Sodium/iodide symporter gene transfection increases radionuclide uptake in human cisplatin-resistant lung cancer cells. Chai W, Yin X, Ren L, Cai M, Long T, Zhou M, Tang Y, Yang N, Hu S. Clin Transl Oncol; 2015 Oct; 17(10):795-802. PubMed ID: 26115738 [Abstract] [Full Text] [Related]
13. Effective treatment of pancreatic neuroendocrine tumours transfected with the sodium iodide symporter gene by 186Re-perrhenate in mice. Riese CG, Seitz S, Schipper ML, Behr TM. Eur J Nucl Med Mol Imaging; 2009 Nov; 36(11):1767-73. PubMed ID: 19449003 [Abstract] [Full Text] [Related]
14. 99mTcO4- accumulation in scintigraphy and expression of Na+/I- symporter in salivary gland tumors. Akai A, Yamamura Y, Nonaka M, Yoshihara T. Auris Nasus Larynx; 2014 Dec; 41(6):532-8. PubMed ID: 25199743 [Abstract] [Full Text] [Related]
15. Endovascular beta irradiation for prevention of restenosis using solution radioisotopes: pharmacologic and dosimetric properties of rhenium-188 compounds. Knapp FF, Guhlke S, Beets AL, Lin WY, Stabin M, Amols H, Weinberger J. Cardiovasc Radiat Med; 1999 Dec; 1(1):86-97. PubMed ID: 11272362 [Abstract] [Full Text] [Related]
16. Evaluation of [18F]-tetrafluoroborate as a potential PET imaging agent for the human sodium/iodide symporter in a new colon carcinoma cell line, HCT116, expressing hNIS. Weeks AJ, Jauregui-Osoro M, Cleij M, Blower JE, Ballinger JR, Blower PJ. Nucl Med Commun; 2011 Feb; 32(2):98-105. PubMed ID: 21085047 [Abstract] [Full Text] [Related]
17. Functional expression of sodium iodide symporter (NIS) in human breast cancer tissue. Upadhyay G, Singh R, Agarwal G, Mishra SK, Pal L, Pradhan PK, Das BK, Godbole MM. Breast Cancer Res Treat; 2003 Jan; 77(2):157-65. PubMed ID: 12602914 [Abstract] [Full Text] [Related]
18. Reversing the silencing of reporter sodium/iodide symporter transgene for stem cell tracking. Kim YH, Lee DS, Kang JH, Lee YJ, Chung JK, Roh JK, Kim SU, Lee MC. J Nucl Med; 2005 Feb; 46(2):305-11. PubMed ID: 15695791 [Abstract] [Full Text] [Related]
19. Small-animal radionuclide luminescence imaging of thyroid and salivary glands with Tc99m-pertechnetate. Boschi F, Pagliazzi M, Rossi B, Cecchini MP, Gorgoni G, Salgarello M, Spinelli AE. J Biomed Opt; 2013 Jul; 18(7):76005. PubMed ID: 23843083 [Abstract] [Full Text] [Related]
20. Rhenium-188 as an alternative to Iodine-131 for treatment of breast tumors expressing the sodium/iodide symporter (NIS). Dadachova E, Bouzahzah B, Zuckier LS, Pestell RG. Nucl Med Biol; 2002 Jan; 29(1):13-8. PubMed ID: 11786271 [Abstract] [Full Text] [Related] Page: [Next] [New Search]